EBNEO commentary: Patent ductus arteriosus (PDA)-To treat early or not with ibuprofen?
Javed, Rashida Gowda, Harsha
Javed, Rashida
Gowda, Harsha
Abstract
Patent ductus arteriosus (PDA) is common in extreme preterm infants, and its management is a subject of debate.2 A large PDA of more than 1.5 mm in diameter which is persistent beyond 3 days of age is associated with a higher mortality and morbidity as well as a greater risk of bronchopulmonary dysplasia.
Systematic reviews of randomised, controlled trials showed that pharmacological treatment with ibuprofen-induced PDA closure had no beneficial effects on clinical outcomes. Therefore, the pharmacological treatment of PDA in extreme preterm infants has decreased.6 However, the evidence to support this strategy is limited and contradictory.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2024-04-30
Type
Article
Subject
Collections
Citation
Javed R, Gowda H. EBNEO commentary: Patent ductus arteriosus (PDA)-To treat early or not with ibuprofen? Acta Paediatr. 2024 Jul;113(7):1734-1735. doi: 10.1111/apa.17259. Epub 2024 Apr 30.